(Q36251326)

13 August 2017

1 reference

title

Management of the patient and family with neurofibromatosis 2: a consensus conference statement (English)

1 reference

neurofibromatosis type II

13 August 2017

1 reference

1 reference

1

1 reference

13 August 2017

Baser ME

2

1 reference

13 August 2017

O'Reilly B

3

1 reference

13 August 2017

Rowe J

4

1 reference

13 August 2017

Gleeson M

5

1 reference

13 August 2017

Saeed S

6

1 reference

13 August 2017

King A

7

1 reference

13 August 2017

Huson SM

8

1 reference

13 August 2017

Kerr R

9

1 reference

13 August 2017

Thomas N

10

1 reference

13 August 2017

Irving R

11

1 reference

13 August 2017

MacFarlane R

12

1 reference

13 August 2017

Ferner R

13

1 reference

13 August 2017

McLeod R

14

1 reference

13 August 2017

Moffat D

15

1 reference

13 August 2017

Ramsden R

16

1 reference

13 August 2017

publication date

1 February 2005

1 reference

British Journal of Neurosurgery

13 August 2017

published in

1 reference

13 August 2017

volume

19

1 reference

13 August 2017

issue

1

1 reference

13 August 2017

page(s)

5-12

1 reference

A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F02688690500081206

Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690500081206

The neuroimaging and clinical spectrum of neurofibromatosis 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690500081206

Neurofibromatosis 2 in the pediatric population

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690500081206

Probability of bilateral disease in people presenting with a unilateral vestibular schwannoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690500081206

Differential diagnosis of type 2 neurofibromatosis: molecular discrimination of NF2 and sporadic vestibular schwannomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690500081206

Predictors of the risk of mortality in neurofibromatosis 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690500081206

Focal amyotrophy in neurofibromatosis 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690500081206

Ocular abnormalities in neurofibromatosis 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690500081206

Malignant peripheral nerve sheath tumours in neurofibromatosis 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690500081206

The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690500081206

Screening for germ-line mutations in the NF2 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690500081206

Somatic mosaicism in neurofibromatosis 2: prevalence and risk of disease transmission to offspring

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690500081206

Molecular study of frequency of mosaicism in neurofibromatosis 2 patients with bilateral vestibular schwannomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690500081206

Molecular analysis of the NF2 tumor-suppressor gene in schwannomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690500081206

Factors associated with survival in patients with meningioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690500081206

Use of MRI and audiological tests in presymptomatic diagnosis of type 2 neurofibromatosis (NF2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690500081206

Clinical experience with gamma knife stereotactic radiosurgery in the management of vestibular schwannomas secondary to type 2 neurofibromatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690500081206

Malignant transformation of a vestibular schwannoma after gamma knife radiosurgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690500081206

Evaluation of clinical diagnostic criteria for neurofibromatosis 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690500081206

Vestibular schwannoma growth in patients with neurofibromatosis Type 2: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02688690500081206

10.1080/02688690500081206

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference